Patent Office Litigation Update: Patent Zombies

In the nine months since the new contested proceedings became operational at the United States Patent & Trademark Office, over 300 Inter Partes Reviews and Covered Business Method proceedings have been petitioned at the new Patent Trial and Appeal Board. The new proceedings can catch unaware patent owners off guard, rendering them "patent zombies" who are already dead in terms of their patent enforcement strategy. Robert Greene Sterne, a founding director at the intellectual property law firm Sterne, Kessler, Goldstein & Fox See more +
In the nine months since the new contested proceedings became operational at the United States Patent & Trademark Office, over 300 Inter Partes Reviews and Covered Business Method proceedings have been petitioned at the new Patent Trial and Appeal Board. The new proceedings can catch unaware patent owners off guard, rendering them "patent zombies" who are already dead in terms of their patent enforcement strategy. Robert Greene Sterne, a founding director at the intellectual property law firm Sterne, Kessler, Goldstein & Fox P.L.L.C., gives the five facts every accused infringer needs to know when contemplating the use of the new contested proceedings. See less -

Embed Video

Copy

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Sterne, Kessler, Goldstein & Fox P.L.L.C. | Attorney Advertising

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×